Stock Fundamentals

Company Information

Company Name
Sagimet Biosciences Inc. Series A Common Stock
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US7867001049
CIK: 0001400118
CUSIP: 786700104
Currency: USD
Full Time Employees: 16
Phone: 650 561 8600
Fiscal Year End: December
IPO Date: Jul 14, 2023
Description:

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Address:

155 Bovet Road, San Mateo, CA, United States, 94402

Directors & Officers

Name Title Year Born
Mr. David A. Happel CEO, President & Director 1962
Ms. Elizabeth Rozek Esq., J.D. Chief Legal & Administrative Officer 1972
Mr. Urs Greber Ph.D. Co-Founder NA
Dr. Lucas Pelkmans Ph.D. Co-Founder NA
Mr. Thierry Chauche CFO & Principal Accounting Officer 1976
Dr. Marie O'Farrell Ph.D. Chief Scientific Officer NA
Mr. Robert D'Urso Senior Vice President of New Products NA
Dr. Andreas Grauer M.D. Chief Medical Officer 1961

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 10, 2026 David Happel N/A Sale 12.10K $5.36 $64.86K
Feb 10, 2026 Thierry Chauche N/A Sale 1.31K $5.36 $7.03K
Nov 20, 2025 George Kemble N/A Sale 37.69K $7.69 $289.82K
Jul 21, 2025 David Happel N/A Sale 65.48K $9.13 $597.81K
Jul 21, 2025 Eduardo Bruno Martins N/A Sale 8.28K $9.13 $75.57K
Jul 21, 2025 Elizabeth Rozek N/A Sale 10.78K $9.13 $98.42K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 1.26M Dec 31, 2025 2.04% $0.00 4.68%
Vanguard Capital Management, LLC 1.10M Mar 31, 2026 1.78% $0.00 0.00%
Woodline Partners LP 1.00M Mar 31, 2026 1.62% $0.02 0.00%
Marshall Wace Asset Management Ltd 966.25K Mar 31, 2026 1.56% $0.01 23.81%
Baker Bros Advisors LP 953.00K Mar 31, 2026 1.54% $0.03 0.00%
Affinity Asset Advisors, LLC 868.02K Mar 31, 2026 1.41% $0.23 -24.40%
Millennium Management LLC 862.30K Mar 31, 2026 1.40% $0.00 46.91%
BlackRock Inc 799.94K Mar 31, 2026 1.30% $0.00 -1.72%
Hillhouse Capital Advisors, Ltd. 724.80K Dec 31, 2025 1.17% $0.14 0.00%
Renaissance Technologies Corp 625.47K Mar 31, 2026 1.01% $0.01 82.62%
D. E. Shaw & Co LP 411.57K Mar 31, 2026 0.67% $0.00 -15.23%
Blue Owl Capital Holdings LP 333.88K Mar 31, 2026 0.54% $0.47 -73.16%
Geode Capital Management, LLC 309.52K Mar 31, 2026 0.50% $0.00 4.62%
Hudson Bay Capital Management LP 303.22K Mar 31, 2026 0.49% $0.01 -0.41%
Bridgeway Capital Management, LLC 299.64K Mar 31, 2026 0.49% $0.03 0.00%
UBS Group AG 293.93K Mar 31, 2026 0.48% $0.00 45.69%
Dimensional Fund Advisors, Inc. 271.22K Mar 31, 2026 0.44% $0.00 99.37%
Pale Fire Capital SE 221.88K Dec 31, 2025 0.36% $0.09 0.00%
Point72 Asset Management, L.P. 187.56K Mar 31, 2026 0.30% $0.00 6.67%
Qube Research & Technologies 182.74K Mar 31, 2026 0.30% $0.00 64.11%

Shares Statistics

Shares Outstanding: 61.18M
Shares Float: 59.14M
% Insiders: 349.60%
% Institutions: 2,193.30%
Short % Float: 13.60%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 778.73K 1.26% ▲ 0.00% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 631.51K 1.02% ▲ 117.48% Apr 30, 2026
3 BlackRock Health Sciences Opps Inv A 585.18K 0.95% ▲ 0.00% Apr 30, 2026
4 abrdn Life Sciences Investors 566.11K 0.92% ▲ 77.99% May 31, 2026
5 Fidelity Extended Market Index 297.34K 0.48% ▲ 103.68% Apr 30, 2026
6 iShares Biotechnology ETF 253.73K 0.41% ▲ 32.93% May 29, 2026
7 Bridgeway Ultra-Small Company 244.54K 0.40% ▲ 0.00% Mar 31, 2026
8 BlackRock Health Sciences Term Trust 220.23K 0.36% ▼ 7.46% Dec 31, 2025
9 Blackrock Extended Mkt Fund CF 139.77K 0.23% ▲ 120.41% Apr 30, 2026
10 Dimensional US Small Cap ETF 135.25K 0.22% ▲ 2.39% May 29, 2026

Valuation Metrics

Enterprise Value: $350.61M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $455.11M
Book Value: $3.14
Earnings/Share: $-1.35
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -23.99%
ROE (TTM): -36.04%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 22.82x 0.00x 0.04x N/A 0.00x
2024-12-31 34.30x 0.00x 0.03x N/A 0.00x
2023-12-31 17.09x 0.00x 0.06x N/A 0.00x
2022-12-31 6.21x 0.00x 6.66x N/A 0.00x
2021-12-31 24.04x 0.00x 3.68x N/A -0.01x
2020-12-31 35.99x 0.00x 2.97x N/A -0.01x
2019-12-31 5.21x 0.00x 12.23x -221.23x -0.01x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SGMT.US!